The Many Faces of Recreational Drug Use - Episode 1
Drug addiction is a devastating condition that affects the quality of the user and their families. In this podcast series, we explore the behaviors of individuals who abuse opioids and stimulants, and learn about their patterns of use and motivations to compel them to continue using these drugs through a series of candid interviews with opioid and stimulant recreational drug users.
Contract Pharma: Altasciences Appoints Dr. Bruce Frank as VP, CDMO Operations
Alzamend Neuro Announces It Has Contracted with Altasciences to Conduct a Phase I Relative Bioavailability Study for AL001 for Dementia Related to Alzheimer's Disease in September 2021
Proactive: Emyria Signs Pure CBD Agreement with U.S.-based Altasciences to Help Fast Track Registration
Proactive: Emyria to Accelerate FDA and TGA CBD Registration Programs with Altasciences Deal
Up Close and Personal with Dr. David Nguyen, MD, MBA
.custom-column-left-text {
float: left;
width: 50%;
padding-right: 10px;
}
.custom-column-right-text {
float: right;
width: 45%;
text-align:center;
}
@media only screen and (max-width: 600px) {
.custom-column-left-text,
.custom-column-right-text,
.custom-column-flc-ebook-text {
float:none;
width:80%;
margin:0 auto;
}
}
Dr.
Ethnobridging Supports Global Clinical Development
.custom-column-left-text {
float: left;
width: 50%;
padding-right: 10px;
}
.custom-column-right-text {
float: right;
width: 45%;
text-align:center;
}
@media only screen and (max-width: 600px) {
.custom-column-left-text,
.custom-column-right-text,
.custom-column-flc-ebook-text {
float:none;
width:80%;
margin:0 auto;
}
}
In our February 2021 blog we discussed protocol design concepts for ethnobridging in Phase I clinical trials.